Matches in SemOpenAlex for { <https://semopenalex.org/work/W2991103090> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2991103090 endingPage "535" @default.
- W2991103090 startingPage "528" @default.
- W2991103090 abstract "Abstract Nivolumab 3 mg/kg every 2 weeks (Q2W) has been approved in Japan for various cancers; however, use of a flat dose is expected to simplify dosing and administration. A quantitative clinical pharmacology approach was used to assess the benefit‐risk profile of nivolumab 240 mg Q2W relative to the approved dose of nivolumab 3 mg/kg Q2W in Japanese patients. Three exposure‐response safety analyses were performed for adverse events that led to discontinuation/death, were grade 3 or higher, and were immune‐mediated and grade 2 or higher for Japanese patients diagnosed with one of multiple tumor types. Exposure‐response analyses of efficacy were evaluated for overall survival and objective response rate. Exposures of nivolumab 240 mg Q2W were 37% higher than those of nivolumab 3 mg/kg Q2W in Japanese patients across the tumor types analyzed. Predicted safety profiles at the two doses differed by less than 2% across tumor types for adverse events leading to discontinuation/death, adverse events of grade 3 or higher, or immune‐mediated adverse events of grade 2 or higher. In addition, the predicted 1‐year and 2‐year overall survival rates, the mean overall survival and the objective response rates were comparable between the doses regardless of the tumor type analyzed. Overall, these results demonstrated that the benefit‐risk of nivolumab 240 mg Q2W was comparable to that of the previously approved 3 mg/kg Q2W dosing regimen, and was the basis for the approval of the 240 mg Q2W as an alternative dosing regimen for treatment in Japanese patients across multiple tumor types." @default.
- W2991103090 created "2019-12-05" @default.
- W2991103090 creator A5000890710 @default.
- W2991103090 creator A5017187133 @default.
- W2991103090 creator A5060980991 @default.
- W2991103090 creator A5072754070 @default.
- W2991103090 creator A5073610874 @default.
- W2991103090 creator A5083885025 @default.
- W2991103090 creator A5091521924 @default.
- W2991103090 date "2020-01-21" @default.
- W2991103090 modified "2023-09-30" @default.
- W2991103090 title "Benefit‐risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers" @default.
- W2991103090 cites W1993519240 @default.
- W2991103090 cites W2005475183 @default.
- W2991103090 cites W2015186160 @default.
- W2991103090 cites W2066671159 @default.
- W2991103090 cites W2160834915 @default.
- W2991103090 cites W2183144139 @default.
- W2991103090 cites W2565164803 @default.
- W2991103090 cites W2567068937 @default.
- W2991103090 cites W2587297698 @default.
- W2991103090 cites W2600124489 @default.
- W2991103090 cites W2612703804 @default.
- W2991103090 cites W2615652585 @default.
- W2991103090 cites W2741564119 @default.
- W2991103090 cites W2754555242 @default.
- W2991103090 cites W2754947201 @default.
- W2991103090 cites W2768379094 @default.
- W2991103090 cites W2793180707 @default.
- W2991103090 doi "https://doi.org/10.1111/cas.14252" @default.
- W2991103090 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7004547" @default.
- W2991103090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31773815" @default.
- W2991103090 hasPublicationYear "2020" @default.
- W2991103090 type Work @default.
- W2991103090 sameAs 2991103090 @default.
- W2991103090 citedByCount "10" @default.
- W2991103090 countsByYear W29911030902021 @default.
- W2991103090 countsByYear W29911030902022 @default.
- W2991103090 countsByYear W29911030902023 @default.
- W2991103090 crossrefType "journal-article" @default.
- W2991103090 hasAuthorship W2991103090A5000890710 @default.
- W2991103090 hasAuthorship W2991103090A5017187133 @default.
- W2991103090 hasAuthorship W2991103090A5060980991 @default.
- W2991103090 hasAuthorship W2991103090A5072754070 @default.
- W2991103090 hasAuthorship W2991103090A5073610874 @default.
- W2991103090 hasAuthorship W2991103090A5083885025 @default.
- W2991103090 hasAuthorship W2991103090A5091521924 @default.
- W2991103090 hasBestOaLocation W29911030901 @default.
- W2991103090 hasConcept C121608353 @default.
- W2991103090 hasConcept C126322002 @default.
- W2991103090 hasConcept C197934379 @default.
- W2991103090 hasConcept C2777288759 @default.
- W2991103090 hasConcept C2777701055 @default.
- W2991103090 hasConcept C2778715236 @default.
- W2991103090 hasConcept C2780030458 @default.
- W2991103090 hasConcept C2781413609 @default.
- W2991103090 hasConcept C71924100 @default.
- W2991103090 hasConceptScore W2991103090C121608353 @default.
- W2991103090 hasConceptScore W2991103090C126322002 @default.
- W2991103090 hasConceptScore W2991103090C197934379 @default.
- W2991103090 hasConceptScore W2991103090C2777288759 @default.
- W2991103090 hasConceptScore W2991103090C2777701055 @default.
- W2991103090 hasConceptScore W2991103090C2778715236 @default.
- W2991103090 hasConceptScore W2991103090C2780030458 @default.
- W2991103090 hasConceptScore W2991103090C2781413609 @default.
- W2991103090 hasConceptScore W2991103090C71924100 @default.
- W2991103090 hasIssue "2" @default.
- W2991103090 hasLocation W29911030901 @default.
- W2991103090 hasLocation W29911030902 @default.
- W2991103090 hasLocation W29911030903 @default.
- W2991103090 hasOpenAccess W2991103090 @default.
- W2991103090 hasPrimaryLocation W29911030901 @default.
- W2991103090 hasRelatedWork W129985863 @default.
- W2991103090 hasRelatedWork W2085208618 @default.
- W2991103090 hasRelatedWork W2966550835 @default.
- W2991103090 hasRelatedWork W2991103090 @default.
- W2991103090 hasRelatedWork W3064391356 @default.
- W2991103090 hasRelatedWork W3105903533 @default.
- W2991103090 hasRelatedWork W3174768752 @default.
- W2991103090 hasRelatedWork W3200799260 @default.
- W2991103090 hasRelatedWork W4280556106 @default.
- W2991103090 hasRelatedWork W4283264643 @default.
- W2991103090 hasVolume "111" @default.
- W2991103090 isParatext "false" @default.
- W2991103090 isRetracted "false" @default.
- W2991103090 magId "2991103090" @default.
- W2991103090 workType "article" @default.